Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $26.49M.
ENTERPRISE VALUE (EV)
$26.49M
Edesa Biotech, Inc.
Market Cap
$37.28M
Enterprise Value (EV)
$26.49M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Edesa Biotech, Inc. (EDSA) | $37.28M | $26.49M |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.61M | $27.28M |
| Incannex Healthcare Limited (IXHL)vs › | $38.16M | N/A |
| DocGo Inc. (DCGO)vs › | $36.05M | $36.73M |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.97M | $76.67M |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.15M | $28.27M |
| Elutia Inc (ELUT)vs › | $34.84M | $25.73M |
| Nephros, Inc. (NEPH)vs › | $39.90M | $36.07M |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.92M | $38.61M |
| Accuray Incorporated (ARAY)vs › | $34.46M | $177.71M |
Market Cap
$37.28M
Total Debt
$0.00
Cash
$10.79M
Enterprise Value
$26.49M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
